Search - tctmd.com

Displaying 121 - 140 of 232

Sort: Relevancy | Date

FDA: Some Tainted Losartan Must Remain on US Market to Maintain Adequate Access for Patients

News Daily News

FDA: Some Tainted Losartan Must Remain on US Market to Maintain Adequate Access for Patients

March 21, 2019

FDA Provides Update on Tainted ARB Investigation, With New Impurity Found

News Daily News

FDA Provides Update on Tainted ARB Investigation, With New Impurity Found

March 04, 2019

Mortality Data ‘Inadvertently Omitted’ From IN.PACT Analysis of Paclitaxel-Coated Balloons

News Daily News

Mortality Data ‘Inadvertently Omitted’ From IN.PACT Analysis of Paclitaxel-Coated Balloons

February 19, 2019

IN.PACT Admiral Data Show No Death Difference at 5 Years for Paclitaxel DCBs vs PTA in Femoropopliteal Disease

News Daily News

IN.PACT Admiral Data Show No Death Difference at 5 Years for Paclitaxel DCBs vs PTA in Femoropopliteal Disease

January 25, 2019

Two Trials Halted in Wake of Study Linking Paclitaxel-Coated Devices to Deaths in PAD

News Daily News

Two Trials Halted in Wake of Study Linking Paclitaxel-Coated Devices to Deaths in PAD

December 17, 2018

Global Investigative Journalism Initiative Takes Aim at Medical Device Industry

News Daily News

Global Investigative Journalism Initiative Takes Aim at Medical Device Industry

November 26, 2018

FDA Allows Claim About Oleic Acid’s Possible Heart Benefits on Labeling

News Daily News

FDA Allows Claim About Oleic Acid’s Possible Heart Benefits on Labeling

November 19, 2018

The Price of Knowledge: Industry-Sponsored Studies in the Era of Evidence-Based Medicine

News Features

The Price of Knowledge: Industry-Sponsored Studies in the Era of Evidence-Based Medicine

October 22, 2018

‘The Bleeding Edge’ Documentary, Tackling Medical Device Regulation, Spurs Diverse Cardiology Reactions

News Daily News

‘The Bleeding Edge’ Documentary, Tackling Medical Device Regulation, Spurs Diverse Cardiology Reactions

Yael L. Maxwell

August 17, 2018

TCTMD’s Top 10 Most Popular Stories for July 2018

News Daily News

TCTMD’s Top 10 Most Popular Stories for July 2018

August 01, 2018

Data or Money: What’s Holding Back Cerebral Embolic Protection in TAVR?

News Conference News The Structural Heart Disease Summit 2018

Data or Money: What’s Holding Back Cerebral Embolic Protection in TAVR?

June 21, 2018

To RCT or Not to RCT? Impella Debate Pivots on How Best to Study Patients on the Brink of Death

News Features

To RCT or Not to RCT? Impella Debate Pivots on How Best to Study Patients on the Brink of Death

May 02, 2018

FDA’s ‘Medical Device Safety Action Plan’ Focuses on Product Life Cycles and Preventing Cyberattacks

News Daily News

FDA’s ‘Medical Device Safety Action Plan’ Focuses on Product Life Cycles and Preventing Cyberattacks

April 20, 2018

FDA’s Proposed Sodium Reduction Plan Could Have a Big Impact, Analysis Suggests

News Daily News

FDA’s Proposed Sodium Reduction Plan Could Have a Big Impact, Analysis Suggests

April 11, 2018

Gout Drug Febuxostat Linked to More CV Deaths Without Uptick in CV Events: CARES Trial

News Conference News ACC 2018

Gout Drug Febuxostat Linked to More CV Deaths Without Uptick in CV Events: CARES Trial

March 14, 2018

FDA Takes on 3-D Printing in Healthcare With Initial Guidance Document

News Daily News

FDA Takes on 3-D Printing in Healthcare With Initial Guidance Document

Yael L. Maxwell

December 06, 2017

It’s Official: Evolocumab Gains Claim for CVD Event Reduction

News Daily News

It’s Official: Evolocumab Gains Claim for CVD Event Reduction

Michael O'Riordan

December 04, 2017

TRACER: Novel Device Effective in Reducing Severe Degenerative MR Over 6 Months

News Conference News TCT 2017

TRACER: Novel Device Effective in Reducing Severe Degenerative MR Over 6 Months

Yael L. Maxwell

November 01, 2017

Evolocumab ‘Abjectly Fails’ Another Financial Stress Test

News Daily News

Evolocumab ‘Abjectly Fails’ Another Financial Stress Test

Michael O'Riordan

October 19, 2017

FDA Expands CoreValve Indication to Include Intermediate-Risk Patients

News Daily News

FDA Expands CoreValve Indication to Include Intermediate-Risk Patients

Michael O'Riordan

July 10, 2017

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.